,Australia

SOPHiA GENETICS takes home two accolades at the Healthcare Asia Medtech Awards

The company was recognised for its genomic application, Solid Tumor Plus Solution (STS+).

SOPHiA GENETICS bagged both the Hospital Partnership of the Year - Australia and Oncology Product Innovation of the Year - Australia trophies at the recently concluded Healthcare Asia Medtech Awards. The awards programme aims to recognise medtech companies that have made a remarkable impact on their clients and cancer management.

SOPHiA GENETICS was recognised for assisting one of its Indian clients with their Solid Tumor Solution plus, a solid tumor profiling application that accelerates the assessment and reporting of 42 DNA-based variants and 137 RNA-based gene fusion detection by combining analytical performance* with the SOPHiA DDM™ platform interpretation capabilities.

SOPHiA GENETICS Solid Tumor Plus Solution is an all-in-one targeted profiling solution that supports the detection of SNVs, large indels, gene amplification, MSI status and gene fusions. The solution is part of the SOPHiA DDM™ platform that combines highly optimized analytical performance* for the aforementioned variants, variant-preclassification and streamlined interpretation in one fully integrated bioinformatic (from data to report) workflow. The workflow offers several features that simplify and accelerate the assessment and reporting of complex genomic variants in the context of solid tumor profiling.

On top of accuracy, ease of use and flexibility, the workflow guarantees data protection and support for its users, to ensure confidence and fast resolution of any disruption. Ultimately  – users can easily export their analysis in a report that can be shared with their peers.

 

Hear from Elise Hogan, APAC Vice President of Sales, as she discusses the trailblazing movement of democratizing data-driven medicine and their award-winning genomic application, the Solid Tumor Plus Solution (STS+).

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

The loss will not have any material impact on the company.
Around 66 hotels have submitted to offer their rooms for hotel isolation.
He has been acting as group CEO since September 2021.
Bidding for these projects may commence in the first half of 2022.
Cardholders can now seek treatment from units where they did not register.
The system will be implemented this year.
The new facility will provide care for Indonesians who get treatment overseas.
The system was the only one of its kind in the country.
Healthcare Asia will be back on 3 January 2022. 
The additional patents aim to address supply issues.
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
Despite NCDs accounting for 41 million deaths annually, they are still healthcare's 'blind spot', expert says.
The gala was held in celebration of World AIDS Day 2021.
It won in the International Human-Machine Competition on Diabetes Management.
The new facility is the first of its kind in Singapore.